Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,293

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,293 results for “glaucoma”

Learn how ShareScore rates datasets ↗
zenodo44/100

Data to "Point-wise correlations between 10-2 Humphrey visual field and OCT data in open angle glaucoma"

<p>This record contains experimental and analysis scripts (written in Matlab)&nbsp;as well as raw and processed data to reproduce the results shown in:</p> <p>Cirafici, P., Maiello, G., Ancona, C., Masala, A., Traverso, C.E., &amp; Iester M. (in press) Point-wise correlations between Humphrey visual field and OCT data in open angle glaucoma. Eye</p>

opencc-by-4.0May 2020View details →
zenodo44/100

Data on eye movements in people with glaucoma and peers with normal vision

<p>Eye movements were recorded from 44 elderly glaucoma patients and 32 age-similar healthy vision controls whilst watching&nbsp;three separate small video clips.</p>

opencc-by-nd-4.0Apr 2018View details →
zenodo44/100

Case study on hereditary divergence and its impact on glaucoma

<p>The data extracted from the <a href="http://Disgenet.org/">DisGeNET </a>database are processed using available open sources tools (VEP, polyphen, SIFT, and ClueGo). The process of data analysis is given in the book chapter.</p>

opencc-by-4.0Oct 2019View details →
zenodo44/100

Risk factor prediction for Secondary Glaucoma amongst patients presenting with Pseudo exfoliation Syndrome (PEX) at Ophthalmology OPD in a Tertiary Care Centre in Ahmedabad

<p>Here we are uploading a data sheet of the<strong> &quot;Risk factor prediction for Secondary Glaucoma amongst patients presenting with Pseudo exfoliation Syndrome (PEX) at Ophthalmology OPD in a Tertiary Care Centre in Ahmedabad.&quot;&nbsp;</strong></p>

opencc-by-4.0Mar 2023View details →
zenodo44/100

Data on eye movements of glaucoma patients with asymmetrical visual field loss during free viewing.

<p>Raw eye tracking data and processed eye movement data were recorded from fifteen participants with assymmetrical visual field loss (visual field worse in one eye) while they freely viewed 270 images of nature with each eye monocularly.</p>

opencc-by-4.0Mar 2023View details →
zenodo44/100

Data to: "Despite impaired binocular function, binocular disparity integration across the visual field is spared in normal aging and glaucoma"

<p>This record contains experimental and analysis scripts (written in Matlab)&nbsp;as well as raw and processed data to reproduce the results shown in:</p> <p>Maiello G., &amp; Kwon, M.&nbsp;(in press) Despite impaired binocular function, binocular disparity integration across the visual field is spared in normal aging and glaucoma. IOVS</p> <p>A preprint version of the manuscript is available at: https://doi.org/10.1101/2022.11.28.518250</p>

opencc-by-4.0Apr 2023View details →
zenodo40/100

A Fundus Image Dataset for RDD-Net in Glaucoma diagnosis

<p>我们为 RDD-Net 提供了眼底图像数据集,包括 4 种不同的医疗数据集。<br>此数据集基于 REFUGE2[1] 数据集、RIM-ONE[2] 数据集、ORIGA[3] 数据集和 Harvard[4] 数据集。我们感谢 [1-4] 名作者所付出的努力。</p> <p>Refuge2 数据集详细信息</p> <table> <tbody> <tr> <td>断层</td> <td>样本数量</td> </tr> <tr> <td>火车</td> <td>1200</td> </tr> <tr> <td>瓦尔</td> <td>400</td> </tr> <tr> <td>测试</td> <td>400</td> </tr> </tbody> </table> <p>超越高峰</p> <table> <tbody> <tr> <td>领域</td> <td>每个领域案例(训练/测试)</td> </tr> <tr> <td>避难所2</td> <td>1400/600</td> </tr> <tr> <td>RIM-ONE</td> <td>339/146</td> </tr> <tr> <td>奧利加</td> <td>454/196</td> </tr> <tr> <td>學術</td> <td>1234/310</td> </tr> </tbody> </table> <p>[1] Fang, H. 等:REFUGE2 挑战:青光眼缉多维分析与评估的宝库。收录于:arXiv 预印本 arXiv:2202.08994 (2022)</p> <p>[2] Fumero,F.,等人:RIM-ONE:用于视神经评估的开放视网膜图像数据库,在:基于计算机的医疗系统国际研讨会-CBMS,第 1-6 页(2011 年)</p> <p>[3] Zhuo, Z. 等:Origa-light:用于青光眼分析和&nbsp;研究的在线视网膜图像数据库,载于:IEEE Eng.在医学领域和 Bio。社会。第3065-3068页 (2010)</p> <p>[4] Ahn, JM 等人:&nbsp;使用眼底照相检测晚期和早期青光眼的深度学习模型。在:PloS one 13(11),e0207982 (2018)</p> <p>如果您发现该框架提出的研究有用,请考虑按以下方式引用该论文:</p> <pre><code> title={RDD-Net: Randomized Joint Data-Feature Augmentation and Deep-Shallow Feature Fusion Networks for Automated Diagnosis of Glaucoma}, author={Tang, Yilin and Zhang, Min and Feng, Jun}, booktitle={Medical Image Computing and Computer Assisted Intervention -- MICCAI 2024}, year={2024} </code></pre>

opencc-by-4.0Jun 2024View details →
zenodo40/100

Datasets of Vascular Networks Extracted from Retinal Images of Hypertensive Retinopathy and Glaucoma Patients

<p>This dataset contains high resolution images of blood vessels extracted&nbsp; from&nbsp;Digital Retinal Images for Optic Nerve Segmentation Database (DRIONS-DB). It contains 110 blood vessels of individuals of which&nbsp;23.1% are patients with chronic glaucoma while the remaining 76.9%&nbsp;are hypertensive retinopathy patients.&nbsp;</p>

opencc-by-4.0Sep 2018View details →
ClinicalTrials.gov40/100

The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)

ClinicalTrials.gov study NCT02691455. IPD Sharing: YES. Countries: 1. Publications: 17.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov study NCT04285580. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov study NCT02636946. IPD Sharing: YES. Countries: 9. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS)

ClinicalTrials.gov study NCT03654885. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
zenodo36/100

Research data supporting "Localized and controlled delivery of nitric oxide to the conventional outflow pathway via enzyme biocatalysis: towards therapy for glaucoma"

<p>Research data supporting the paper above published at DOI: 10.1002/adma.201604932</p>

opencc-by-4.0Feb 2017View details →
zenodo36/100

OCT volumes for glaucoma detection

<p>OCT volumes used for the training and evaluation of a glaucoma detection classifier as described in</p> <p>A feature agnostic approach for glaucoma detection in OCT volumes<br> https://arxiv.org/abs/1807.04855</p> <p>Volumes are in NumPy format. A viewer is available at https://github.com/maet3608/oct-viewer</p>

opencc-by-nc-4.0Nov 2018View details →
dryad36/100

miRNAs in primary open-angle glaucoma and ocular hypertension

<p>Glaucoma is a chronic neurodegenerative disease, which is the leading cause of irreversible blindness worldwide. As a response to high intraocular pressure, the clinical and molecular glaucoma biomarkers indicate the biological state of the visual system. Classical and uncovering novel biomarkers of glaucoma development and progression, follow-up, and monitoring the response to treatment are key objectives to improve vision outcomes. While the glaucoma imaging field has successfully validated biomarkers of disease progression, there is still a considerable need for developing new biomarkers of early glaucoma, that is, at the preclinical and initial glaucoma stages. Outstanding clinical trials and animal-model study designs, innovative technology, and analytical approaches in bioinformatics are essential tools to successfully uncover novel glaucoma biomarkers with a high potential for translation into clinical practice. To better understand the clinical and biochemical–molecular–genetic glaucoma pathogenesis, we conducted an analytical, observational, and case-comparative/control study in 358 primary open-angle glaucoma (POAG) patients and 226 comparative-control individuals to collect tears, aqueous humor, and blood to process for identifying POAG biomarkers by exploring several biological pathways, such as inflammation, neurotransmitter/neurotrophin alteration, oxidative stress, gene expression, miRNAs fingerprint and its biological targets, and vascular endothelial dysfunction. We are incredibly enthusiastic about gathering as much information as possible on POAG biomarkers to learn how this information can be used to better steer the diagnosis and therapy of glaucoma to prevent blindness in the predictable future.</p>

opencc-zeroMay 2023View details →
ClinicalTrials.gov36/100

Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov study NCT04445519. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular H

ClinicalTrials.gov study NCT04620135. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications

ClinicalTrials.gov study NCT03193736. IPD Sharing: NO. Countries: 2. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov study NCT01241240. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Does Glaucoma Cause Loss of Brain Function?

ClinicalTrials.gov study NCT01303939. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record